Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jan 26, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the effects of yoga-based group therapy on patients with schizophrenia spectrum disorders who are currently receiving treatment in a psychiatric hospital. The goal is to see if adding yoga therapy to their regular treatment helps improve their well-being. Participants in the trial are divided into two groups: one group will take part in the yoga therapy sessions in addition to their usual treatment, while the other group will continue with their usual treatment only. Researchers will assess the participants' progress at the beginning of the study and after four weeks of therapy.

To be eligible for this trial, participants need to be between 18 and 65 years old, be diagnosed with a schizophrenia spectrum disorder, and be able to give their consent to participate. They should also be willing to join group therapy and not be experiencing severe psychotic symptoms or acute suicidality. For those who qualify, joining this study means they will have the opportunity to engage in yoga therapy, which may help them feel better while they continue their regular psychiatric treatment. The trial is currently recruiting participants, and everyone, regardless of gender, is welcome to apply.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • male and female participants
• • treated as psychiatric inpatients at the psychosis ward or in the social-psychiatric day clinic
• • ≥18 years
• • diagnosis of a schizophrenia-spectrum disorder according to the Diagnostical and Statistical Manual 5th edition) and the International Statistical Classification of Diseases and Related Health Problems(ICD-10) code F2
• • ability to give informed consent
• • willingness and ability to engage in psychotherapeutic group therapy
• • low to moderate psychotic state indicated with a score of ≤ 6 for each item at the Positive scale of the Positive and Negative Syndrome Scale (PANSS, Peralta \& Cuesta, 1994)
• Exclusion Criteria:
• • a score \> 6, suggesting an acute psychotic episode with severe psychotic symptoms (Peralta\& Cuesta, 1994)
• • acute suicidality, assessed by item eight of the Calgary Depression Scale for Schizophrenia \> 1 (Addington, Addington, Maticka-Tyndale, \& Joyce, 1992)
• • any neurological disorders that may affect cognitive functioning
• • acute substance abuse other than nicotine and prescribed medication
• • conflicting co-therapy such as electroconvulsive therapy or ketamine treatment